dihydroergocryptine has been researched along with n-(3-iodopropen-1-yl)-2-carbomethoxy-3-(4-chlorophenyl)tropane in 1 studies
| Studies (dihydroergocryptine) | Trials (dihydroergocryptine) | Recent Studies (post-2010) (dihydroergocryptine) | Studies (n-(3-iodopropen-1-yl)-2-carbomethoxy-3-(4-chlorophenyl)tropane) | Trials (n-(3-iodopropen-1-yl)-2-carbomethoxy-3-(4-chlorophenyl)tropane) | Recent Studies (post-2010) (n-(3-iodopropen-1-yl)-2-carbomethoxy-3-(4-chlorophenyl)tropane) |
|---|---|---|---|---|---|
| 21 | 8 | 2 | 25 | 8 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gasser, T; Pöpperl, G; Ruzicka, E; Schwarz, J; Storch, A; Tatsch, K | 1 |
1 trial(s) available for dihydroergocryptine and n-(3-iodopropen-1-yl)-2-carbomethoxy-3-(4-chlorophenyl)tropane
| Article | Year |
|---|---|
Comparison of alpha-dihydroergocryptine and levodopa monotherapy in Parkinson's disease: assessment of changes in DAT binding with [123I]IPT SPECT.
Topics: Adolescent; Aged; Caudate Nucleus; Dihydroergocryptine; Dopamine Plasma Membrane Transport Proteins; Double-Blind Method; Female; Follow-Up Studies; Humans; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Neostriatum; Nerve Tissue Proteins; Parkinson Disease; Putamen; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tropanes | 2004 |